PDK Labs
This article was originally published in The Tan Sheet
Executive Summary
Negotiating to acquire herbal and botanical extract supplier Dr. Madis Labs, PDK announced May 2. PDK, which manufactures and distributes OTCs and vitamins, said it has entered into a letter of intent with the Chapter 11 trustee of the Dr. Madis estate to acquire substantially all assets of the company for an aggregate purchase price of approximately $2.4 mil. The acquisition is subject to approval by the bankruptcy court. Dr. Madis had 1993 sales of $5.2 mil.; PDK sales for the year ended Nov. 30,1993 were $18.7 mil
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning